- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05061966
The Digital Wellbeing Project
June 1, 2023 updated by: University of Pennsylvania
Piloting a Web App for Sexual and Gender Minority Youth Mental Health
This goal of this randomized control trial is to test whether a web application that provides sexual and gender minority youth ages 13-19 (N=200) with tools for affirming their identities and coping with minority stress can affect key psychosocial outcomes, such as coping self-efficacy and symptoms of anxiety and depression.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
270
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Pennsylvania
-
Philadelphia, Pennsylvania, United States, 19104
- University of Pennsylvania
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
13 years to 19 years (Child, Adult)
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Are between 13-19 years of age (inclusive)
- Self-identify as a sexual or gender minority
- Are English literate
- Reside within the United States
- Have access to a device that has internet access, a web browser, and SMS capabilities, such as a smartphone, computer, or tablet
- Willingness to participate in study activities
Exclusion Criteria:
- Not between 13-19 years of age (inclusive)
- Does not self-identify as a sexual or gender minority
- Is not English literate
- Does not reside within the United States
- Does not have access to a device that has internet access, a web browser, and SMS capabilities, such as a smartphone, computer, or tablet
- Unwilling to participate in study activities
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Online Resource website
The comparator is a website that includes a list of freely available web-based resources for sexual and gender minority youth.
|
The control will have access to resources on the website, but will not receive any engagement reminders, matching the conditions present in real world contexts in which web-based resource lists are available.
|
Experimental: immi
The intervention is a novel and scalable web application designed to provide sexual and gender minority youth with tools for affirming their identity and coping with minority stress.
|
The intervention has four main content areas: 1) gender identity (the gender guide), 2) sexual orientation (the queerness guide), 3)stress and coping (the stress guide), and 4) internalized stigma (the internalized stigma guide).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Coping Self-efficacy
Time Frame: 4-week follow-up
|
The Stress Appraisals Measure for Adolescents includes three subscales (Challenge subscale; Threat subscale; Resources subscale).
Each of these subscales is answered on a 5-point scale (1=strongly disagree to 5=strongly agree).
A mean score was computed for each subscale, with higher values indicating greater endorsement of each respective stress appraisal.
|
4-week follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Identity Affirmation
Time Frame: 4-week follow-up
|
The Lesbian, Gay and Bisexual Positive Identity Measure-Authenticity Subscale has a scoring range from 1 to 7 (1=strongly disagree to 7=strongly agree).
A mean score was computed, whereby greater values indicate greater feelings of authenticity.
|
4-week follow-up
|
Internalization of Minority Stress
Time Frame: 4-week follow-up
|
The Coping with Discrimination Scale- Internalization Subscale has a scoring range from 1 to 6 (1=never to 6=always).
We computed a mean score, where higher scores indicate greater internalization of blame for minority stress
|
4-week follow-up
|
Sense of Belonging to the Queer Community
Time Frame: 4-week follow-up
|
The Thwarted Belongingness subscale of the Interpersonal Needs Questionnaire is a 5-item scale that is answered on a 7-point scale (1=not at all true" to 7=very true for me).
We computed a sum score ranging from 5 to 35, where higher scores indicate a lack of sense of belonging
|
4-week follow-up
|
Anxiety Symptoms
Time Frame: 4-week follow-up
|
The General Anxiety Disorder-7 scale has a range from 0 to 21. Scores were computed by summing the items.
Higher scores indicate greater anxiety symptomatology.
|
4-week follow-up
|
Depression Symptoms
Time Frame: 4-week follow-up
|
The Patient Health Questionnaire-8 inventory has a range from 0 to 24.
A summed score was computed, where higher scores indicate greater depression symptomatology.
|
4-week follow-up
|
Cognitive and Behavioral Coping Skills
Time Frame: 4-week follow-up
|
The Brief COPE inventory is comprised of 11 subscales: Self-distraction; Active coping; Emotional support; Instrumental support; Venting; Positive reframing; Planning; Acceptance; Self-blame; Substance use; and, Behavioral disengagement.
Participants answered each subscale using a 4-point scale (1="I haven't been doing this at all" to 4="I've been doing this a lot").
A mean score was computed for each subscale, with higher values indicating greater use of that coping skill.
|
4-week follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Jose A Bauermeister, PhD, University of Pennsylvania
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 15, 2021
Primary Completion (Actual)
December 23, 2021
Study Completion (Actual)
July 1, 2022
Study Registration Dates
First Submitted
September 14, 2021
First Submitted That Met QC Criteria
September 24, 2021
First Posted (Actual)
September 30, 2021
Study Record Updates
Last Update Posted (Actual)
June 5, 2023
Last Update Submitted That Met QC Criteria
June 1, 2023
Last Verified
June 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 849509
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
IPD Plan Description
Study variables will be available; however, the investigators will protect the rights and privacy of human subjects by redacting all identifiers from the dataset.
IPD Sharing Time Frame
The investigators will assure the timely release and sharing of data two years after the publication of the main trial findings from the final dataset.
IPD Sharing Access Criteria
The de-identified data from this project will be available through individual requests directed to the Principal Investigator.
IPD Sharing Supporting Information Type
- STUDY_PROTOCOL
- SAP
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Health
-
Chinese University of Hong KongNot yet recruitingMental Health Wellness 1 | Mental Well-being | Mental Health Issue | Precision Mental HealthHong Kong
-
King's College LondonCompletedMental Health Wellness 1 | Mental Health IssueUnited Kingdom
-
Chapin Hall at the University of ChicagoUniversity of ConnecticutCompletedMental Health | Physical Health
-
VA Office of Research and DevelopmentCompletedMental Health | Veterans Health | Rural HealthUnited States
-
National Taiwan Normal UniversityCompletedMental Health | Physical HealthTaiwan
-
Virginia Commonwealth UniversityCompletedMental Health DisordersUnited States
-
Johns Hopkins UniversityEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedMental Health DisordersCongo
-
Norwegian University of Science and TechnologySt. Olavs HospitalCompletedMental Health DisordersNorway
-
University of WarwickKing's College London; KU Leuven; University Hospital, Montpellier; Erasmus Medical... and other collaboratorsUnknownMental Health Disorder | Mental Health ImpairmentIreland, United Kingdom, Netherlands, Germany, Belgium, Croatia, France, Italy
-
York UniversityCanadian Institutes of Health Research (CIHR); North York General HospitalCompletedMental Health DisordersCanada
Clinical Trials on Control
-
Claudia M. WittCompleted
-
University of California, San FranciscoWithdrawn
-
The George InstituteChanghai Hospital; University of CalgaryNot yet recruiting
-
Universidad Nacional de Educación a DistanciaMinisterio de Economía y Competitividad, SpainUnknownChronic Pain | FibromyalgiaSpain
-
University of California, Los AngelesThe National Council on Aging; City of Los Angeles Department of Aging; Los Angeles...Completed
-
Queen's University, BelfastPublic Health Agency, Health and Social Care Research and Development; Tiny...Completed
-
National Taiwan University HospitalEnrolling by invitationCognitive Function | Atrial Fibrillation, PersistentTaiwan
-
Takeshi MorimotoUniversity of the RyukyusActive, not recruitingCoronary Artery Disease | Hypertension | Type 2 Diabetes | DyslipidemiaJapan
-
Johnson & Johnson Vision Care, Inc.TerminatedRefractive Error CorrectionUnited States
-
Vanderbilt University Medical CenterCompleted